[Combination chemotherapy of MCNU and interferon alfa-2a (genetical recombination) for advanced multiple myeloma].
Hino
N
N
Department of Internal Medicine, Kure Mutual Aid Hospital.
Matsuura
W
W
Kawakami
K
K
Ono
T
T
Matsumoto
T
T
Tominaga
T
T
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D009607:Nitrosourea Compounds / Q000008:administration & dosage* / Q000627:therapeutic use; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D007370:Interferon Type I; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D009607:Nitrosourea Compounds; D011994:Recombinant Proteins; C020766:ranimustine